NANO futures EITP The EU scenario in nanotechnology and new perspective in cancer therapy Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
What Why How Example Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
NANO futures environment it’s an HUB for the NANOtechnologies where several actors can interact From industrial sectors, From industrial association and networks From research institute and universities Plus close cooperation with 11 European Technology Platforms Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
Platform Members 495 INDUSTRIALIZATION Brokerage Event 645 The Platform structure guarantees RESEARCH and TECH. a cross-cutting approach: 349 SAFETY 10+1 Horizontal Working Group STANDARDIZATION 268 V4N 235 REGULATION Workshop 355 COMMUNICATION Tech.Transfer and 459 Innovation Financing 442 NETWORKING 319 SKILLS AND EDUCATION CRITICAL ROW 58 MATERIALS SOCIETAL NEW ENGAGEMENT Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
The lighthouse acts as a clear Platform Network connection helping to translate activities/actions to the countries/ regions and vice versa. NANO futures is close to you! 26 Local Contact points and more to come! NANO futures NANO futures Treviso 20-21 Nov. 2015
WHY? Treviso 20-21 Nov. 2015
NANO futures Vision NANOfutures is the European Technology Integrating and Innovation Platform on nanotechnology. Its main objective is to facilitate the nanotechnology development and commercialization by connecting all relevant nanotechnology NANOfutures fosters a responsible development of the Nanotechnologies by balancing: Industrial Profit Safety Quick access Regulation to Market Cost of Research Deep Knowledge All the main actors need to be involved in the process of tracing a Roadmap Companies ¡ Research ¡ Policy ¡Maker ¡ and ¡Industrial ¡ Institution ¡and ¡ and ¡ Clusters ¡ HE ¡ Treviso 20-21 Nov. 2015 Governments ¡
Evolving VISION SOCIETAL CHAIN NANOfutures defines PRODUCT development of products CHAIN in a systematic and VALUE comprehensive way CHAIN considering that each Sustainability major step of a Product Product Value Chain has its Market subchain of activities Growth Design Knowledge Treviso 20-21 Nov. 2015
HOW? Treviso 20-21 Nov. 2015
2012 Roadmapping Activity Approach • Bottom-Up 2015 • Open and Inclusive • Cross-Sectorial • Systematic Structure • Market addressed Value Chains • Actions Sequences in Short-Medium-Long Term • TRL targets Treviso 20-21 Nov. 2015
Roadmapping Activity WHAT’S NEW IN THE IMPLEMENTATION ROADMAP New Actions in the four VC Examples of Pilot Lines Market scenario of those Pilot Lines Consortia examples of those Pilot Lines Treviso 20-21 Nov. 2015
MEDICINE AND PHARMA Roadmapping Activity IN THE ROADMAPS Microfluidics, Nanostructured Nano-pharmaceutical and Lab on chips Coating contrast agent for theranostics ACTIONS ARE DETAILD TOWARD: • Regenerative medicine, diagnostics and drug delivery • Nanoporous and nano- enabled textiles structures and surfaces for smart biomaterials • Microfluidic advanced systems for in vitro diagnostics • Smart chemical and bio sensors for multi-parameter measurements (multiplexing) • Nano- particles/capsules/nanofluids for to be used as nanopharmaceuticals and/or contrast agents Treviso 20-21 Nov. 2015
Roadmap Focus: VCs & Markets Plasma and VC1 - Lightweight Transportation VC2 - Nano- Vacuum multifunctional materials enabled Engineered and sustainable composites Packaging surfaces for Surfaces multi-sectorial Wet Engineered applications Textile and Surfaces ICT Energy sport sector VC7 Construction and buildings VC4 VC3 Infrastructure Alloys Structured ICT ( Nanoelectronics, photonics ) for Multiscale Ceramics, Surfaces Modelling and Transportation Intermetallics Testing Medicine Textile and Energy Energy ( PV Complex Adaptive ( Bio-sensors, Harvesting & Systems for passive batteries, regen. Conversion complete product harvesting ) funct. medicine ) design VC5 Direct manufacturing VC6 Construction Functional Integration of and building Fluids nano Finished net shaped Transportation Household Catalysis Cleaning 3d structures for Semi Medicine and finished optoelectronic &Pharma Cosmetics filtration Cross Sectorial Non-Technological Actions Treviso 20-21 Nov. 2015
SHOT TERM Examples of Actions in Medicine METROLOG ASSEMBL FINAL WASTE TOOLS MATERIALS MODELLING COMPONENTS Y Y PRODUCT TREATMENT TRL 7-8 2D – Integration of technologies with Modeling of increased throughput and nanoparticles definition (S2S, HE, NIL, behavior in active Laser, Litho…) Monitoring systems through re- Methods for of material engineering of actual functionalization TRL 5-6 behavior in 3D – Integration of structured systems during synthesis to films (plastic) into 3D parts use Modeling for reduce production and in-line process interface and steps of nanofillers LEGENDA: development NMP 6 – 2015 : functionalizatio Improvements in the drug loading Improvements in the n particles drug loading SHORT Development of Novel efficiency of lipid based surface efficiency of lipid TERM technology able to Design of MEDIUM based nanoparticles, TRL 1-4 nanoparticles, and synthetic produce in nanomatrices multifunctional TERM and synthetic reproducible way materials inorganic nanomatrices and inorganic LONG complex and tailored for TERM nanomatrices and nanomaterials nanocapsules different needs nanocapsules nanocapsules SAFETY Characterise and control SAFETY mechanical release of Adopt safety by SAFETY NON-TECH nanoparticles to the surface in design into material Understand hazardous nature of biological systems. Understand ACTIONS selection the material appropriate to the hazardous nature of the material specific to the specific route of application, and appropriate to the specific potential translocation of the value chain application, and potential released material in the human translocation of the released body material in the human body Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
MEDIUM TERM Examples of Actions in Medicine METROLOG ASSEMBL FINAL WASTE TOOLS MATERIALS MODELLING COMPONENTS Y Y PRODUCT TREATMENT TRL 7-8 2D – Integration of 2D – Integration of technologies with technologies with Modeling of increased throughput and definition increased throughput and nanoparticles definition (S2S, HE, NIL, (S2S, HE, NIL, Laser, Litho … ) behavior in active Laser, Litho…) Monitoring systems through re- Methods for of material engineering of actual functionalization TRL 5-6 behavior in 3D – Integration of structured systems during synthesis to films (plastic) into 3D parts use Modeling for reduce production and in-line process interface and steps of nanofillers LEGENDA: development functionalizatio Improvements in the n particles drug loading SHORT Development of surface efficiency of lipid TERM technology able to Design of MEDIUM based nanoparticles, TRL 1-4 produce in multifunctional TERM and synthetic reproducible way materials inorganic LONG complex tailored for TERM nanomatrices and nanomaterials different needs nanocapsules SAFETY Characterise and control SAFETY mechanical release of Adopt safety by SAFETY NON-TECH nanoparticles to the surface in design into material Understand hazardous nature of biological systems. Understand ACTIONS selection the material appropriate to the hazardous nature of the material specific to the specific route of application, and appropriate to the specific potential translocation of the value chain application, and potential released material in the human translocation of the released body material in the human body Treviso 20-21 Nov. 2015 Treviso 20-21 Nov. 2015
Recommend
More recommend
